home / stock / opthf / opthf news

OPTHF News and Press, Optimi Health From 11/07/23

Stock Information
Company Name: Optimi Health
Stock Symbol: OPTHF
Market: OTC
Website: optimihealth.ca
Menu
OPTHF OPTHF Quote OPTHF Short OPTHF News OPTHF Articles OPTHF Message Board
Get OPTHF Alerts

News, Short Squeeze, Breakout and More Instantly...
OPTHF - Optimi Health Welcomes Dr. Preston A. Chase as New Chief Science Officer

VANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Canadian psychedelics drug research and formulation company, is delighted to announce the appointment of Dr. Preston A. Chase as the Company’s Chief Science O...
OPTHF - Optimi Health Announces Third and Final Tranche of CAD $1,000,000 Secured for Debt Financing

VANCOUVER, British Columbia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“ Optimi Health ” or the “ Company ”), a Canadian drug research and formulation company licensed by Health Canada to manufacture psychedeli...

OPTHF - Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted Therapy Clinical Trial

VANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, is pleased to see the positive and encouraging outcomes from the MAPS Phase 3 MDMA-Assisted Therapy (MDMA-AT) C...

OPTHF - Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program

VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly announced today that Health Canada has approved an amendment to the Company’s Dealer's Licence. ...
OPTHF - Optimi announces second tranche of C$1M secured for debt financing

2023-09-05 12:40:37 ET More on Optimi Health Corp. Financial information for Optimi Health Corp. For further details see: Optimi announces second tranche of C$1M secured for debt financing

OPTHF - Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing

VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“ Optimi Health ” or the “ Company ”), a Canadian drug research and formulation company licensed by Health Canada to manufacture psychedel...

OPTHF - Optimi Health Announces CAD $3,000,000 Senior Debt Financing

VANCOUVER, British Columbia, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian drug research and formulation company licensed by Health Canada to manufacture psychedelic substances such as MDMA and high-quality, GMP-grade natural psilocybin, i...
OPTHF - Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent

VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research pur...

OPTHF - Optimi Health Announces Receipt of Purported Termination Notice

VANCOUVER, British Columbia, July 27, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”) has received a termination notice and demand for payment pursuant to a definitive supply agreement (the “Supply A...

OPTHF - Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS

VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical re...
Previous 10 Next 10